CBLL vs LEN · rev $65.4M vs rev $34.19B
CeriBell, Inc (CBLL) versus LEN (LEN) — a side-by-side from cached financials, not a winner call.
CeriBell, Inc (CBLL) is a medical devices company listed on US.
LEN (LEN) common stock.
Latest reported CBLL revenue for 2024-12-31 was $65.4M. Net income was -$40.5M. Revenue was up 44.7% from 2023-12-31 to 2024-12-31. CBLL currently screens at market cap $768.1M.
Latest reported LEN revenue for 2025-11-30 was $34.19B. Net income was $2.08B. Revenue was down 3.5% from 2024-11-30 to 2025-11-30. LEN currently screens at market cap $0.
CBLL currently screens at market cap $768.1M. LEN currently screens at market cap $0.
Not investment advice. Open the CBLL and LEN stock pages for the full models.
Not investment advice.